Digital Biomarkers: Catering To The Needs of Modern Healthcare
Roots Analysis
Market research & consulting services in the pharma / biopharma, medical devices & contract manufacturing domains
Digital biomarkers are patient-related physiological and behavioral measures that are captured using various types of digital tools, such as mobile sensors, cameras, headsets, wristbands, sweat-sensing patches, portable ECG devices, digital rings and ankle bands. The digital biomarkers have gained popularity owing to their various advantages, such as early detection of diseases (enabling timely intervention), non-invasive monitoring of symptoms (enhancing patient comfort) and continuous health data collection (facilitating real-time disease management). Further, the trend towards home healthcare has also fueled the demand for digital biomarker solutions, as they are more accessible to patients.
Further, the digital biomarkers domain has witnessed a myriad of innovations, aimed at improving the overall credibility of the solutions and improving data accuracy; examples include diagnosis of early-stage Alzheimer’s disease patients, by evaluating their brain activity during sleep and digital biomarker solutions for identifying changes in speech patterns for detecting early signs of cognitive impairment.
For detailed information:
Email: [email protected]
Digital Biomarkers Market
According to Roots Analysis, the global market for digital biomarkers is estimated to be around USD 5.5 billion in 2024 and expected to grow at a CAGR of 18.5%, during the forecast period 2024-2035. In terms of purpose of solution, majority share (~40%) of the global digital biomarkers market is anticipated to be captured by monitoring digital biomarkers. Further, digital solutions for physiological biomarkers are likely to capture 55% of the digital biomarkers market.
Growth of prefilled syringes market is driven by several factors, such as rising adoption of smartphones and smart wearable devices (enabling continuous monitoring of patient health), increasing number of decentralized clinical trials (for accurate, reliable and real-time health information of trial participants) and increased use of neurological digital biomarkers and mental health digital biomarkers (enabling personalized treatment regimen).
Digital Biomarkers Market Analysis
The digital biomarkers market features the presence of more than 220 digital biomarker solutions, that are currently available / under development for monitoring / treatment of various indications. Of these, over 80% of the digital biomarker solutions are software / applications; notably, the higher availability of these solutions is due to high accessibility and user-friendly interface. Further, more than 40% are physiological digital biomarkers, such as heart rate variability, pulse rate, body temperature and breathing rate.
Overall, the digital biomarker developers landscape seems to be dominated by the presence in small and very small players (~80%). More than 50% of the companies engaged in this domain are presently headquartered in North America (specifically the US), followed by Europe (40%) and Asia-Pacific (5%).
领英推荐
Patenting Activity in Digital Biomarkers Industry
Over 765 patents have been filed by players in the digital biomarker domain; of these, over 70% were patent applications (not having received approval yet) while over 25% were granted patents. In addition, majority of the patents were published in 2023, followed by those published in 2022.
Leading Digital Biomarkers Companies
Examples of key players (which have also been profiled in this report) engaged in developing digital biomarkers include (in alphabetical order) Acculi Labs, ActiGraph, AliveCor, ATCOR, BACtrack, Biogen, BioSerenity, BioSensics, Eyenuk, Empatica, Feel Therapeutics, icometrix, iMediSync, IXICO, Kinsa, Koneksa Health, Kontigo Care, Progentec Diagnostics, Quibim and Vocalis Health.
All your Questions Related to Digital Biomarkers Market Answered in this Report
The Digital Biomarkers Market, till 2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the digital biomarkers, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. The report answers many key questions related to this market. Click on the below link to know more about this emerging area of research.
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.